subject inclusion question in replicate design for ANVISA [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2019-09-04 22:23 (2087 d 02:10 ago) – Posting: # 20542
Views: 3,501

Hi Shuanghe,

❝ […] the client's statistical consultant commented that only subjects who complete all 4 period (2T+2R) should be included, otherwise, they should be excluded even if they completed 3 period.


IMHO, this doesn’t make sense. See the example in the vignette of replicateBE. At least this is what I have I done in my European studies and never got a question about it.

❝ By the way, Helmut, does this belong to Study Assessment or Regulative/Guideline category?


Study Assessment is about ongoing/completed studies. I moved it here.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,678 registered users;
53 visitors (0 registered, 53 guests [including 10 identified bots]).
Forum time: 00:34 CEST (Europe/Vienna)

Being really good at C++ is like being really good
at using rocks to sharpen sticks.    Thant Tessman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5